MedPath

Evaluation of the Effect of Donepezil on the Methadone Consumptio

Phase 2
Conditions
amount of Methadon use.
Registration Number
IRCT20191217045766N1
Lead Sponsor
Kurdistan University of Medical sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
100
Inclusion Criteria

All opioid dependent patients on Methadone agonist therapy in the age range of 18 to 55 years
At least fifth grade elementary education

Exclusion Criteria

Intellectual Disability
Use if Anti Depressant, Carbamazepin, Dexamethasone, Phenobarbital, Phenytoin, Rifampin, Clonidine, Sox, Betanecol
Use of Donepezil during 3 months ago
CAD
Pregnancy and Lactation
major psychiatric disorder
Use of Psychotherapy
Sever sensitivity to Donepezil

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Amount of Methadon use. Timepoint: at the beginning of the study,weeks of 4, 10 and 14. Method of measurement: patients report.;Craving for Methadon. Timepoint: at the beginning of the study,weeks of 4, 10 and 14. Method of measurement: HALIKAS Questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath